Triumeq

Medicinal product

(Invented) name

Triumeq

Active substance (s)

Dolutegraviras/Abakaviras/Lamivudinas

Strength

50 mg/600 mg/300 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR13, Lamivudine, abacavir and dolutegravir

Marketing authorisation holder

ViiV Healthcare BV, Nyderlandai

Date of authorisation

2014-09-01

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Dolutegraviras	50 mg
Abakaviras	600 mg
Lamivudinas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60114	74385	1074385	buteliukas	N30		Receptinis	EU/1/14/940/001	Tiekiama	-	-	No	-	-
60115	74386	1074386	buteliukas	N90 (3x30)		Receptinis	EU/1/14/940/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-09-01	Registruotas